Table: Kobayashi Pharmaceutical - 9-MTH group results
Oct 30 (Reuters)-
Kobayashi Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2017 Dec 31, 2016 Dec 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 107.65 150.00
Operating 17.15 20.00
Recurring 16.99 21.00
Net 11.74 15.10
EPS 149.08 yen 191.73 yen
EPS Diluted 148.86 yen
Ann Div 52.00 yen 54.00 yen
-Q2 div 28.00 yen 25.00 yen
-Q4 div 27.00 yen 26.00 yen
NOTE - Kobayashi Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows